---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-004055"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2026-01-28T23:59:59+00:00"
generated_at: "2026-05-16T07:16:44.743615+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Enveric Biosciences raises ~$1.5M in registered direct offering with warrants

## Summary
- Sold 328,802 shares at $4.41 per share in a registered direct offering, gross proceeds ~$1.5M.
- Concurrent private placement: Series G and H warrants to buy up to 328,802 shares each at $4.16.
- Series G warrants expire 5 years after resale registration effective date; Series H expire 18 months after.
- Net proceeds ~$1.25M for product development, working capital, general corporate purposes.
- H.C. Wainwright acted as placement agent; fees include 7% cash and placement agent warrants.

## SEC filing metadata
- accession: 0001493152-26-004055
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2026-01-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315226004055/0001493152-26-004055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315226004055/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-004055
- JSON: https://secwatch.observer/filing/0001493152-26-004055.json
- Plain text: https://secwatch.observer/filing/0001493152-26-004055.txt

## Key facts
- Material Agreements
  Enveric Biosciences, Inc. entered into Purchase Agreement with certain institutional investors valued at approximately $1.5 million (effective 2026-01-27).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors
  - Value: approximately $1.5 million
  - Effective: 2026-01-27
  source text: On January 27, 2026, Enveric Biosciences, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors (each, an “Investor”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/890821/000149315226004055/0001493152-26-004055-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.